Third Line Eribulin for Triple-negative Metastatic Breast Ductal Carcinoma Resulting in Extended Progression-free Survival of 57 Months

por Manthri, Sukesh, Sharma, Purva, Mejbel, Haider Atheer, Singal, Sakshi, Jaishankar, Devapiran
Publicado 2020